HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Two cases of digitalis toxicity with reversible and severe decrease of visual acuity].

AbstractBACKGROUND:
We performed electrophysiologic tests on two patients with digitalis toxicity who first had photophobia and xanthopsia and revealed reversible reduced visual acuity and binocular central scotoma.
CASES:
The patients were a 72-year-old male and a 54-year-old male who had symptoms of digitalis toxicity.
FINDINGS:
The corrected visual acuity was severely decreased during digitalis toxicity, 0.02 oculus dexter (OD) and 0.1 oculus sinister (OS) in case 1 and 0.04 OD and 0.2 OS in case 2. But visual acuity recovered as the blood levels of digitalis decreased to the normal level and the corrected visual acuity was 0.7 OD and 0.8 OS in case 1 and 0.8 OD and 0.9 OS in case 2. We recorded 30 Hz-flicker electroretinogram (ERG), single flash ERG, photopic ERG, and scotopic ERG when digitalis blood levels were elevated and normal. Decreased amplitudes of 30 Hz-flicker ERG and photopic ERG suggested that photoreceptor function was disturbed at digitalis toxicity and cone dysfunction was more severely disturbed than rod dysfunction.
CONCLUSION:
30 Hz-flicker ERG, as well as electrocardiogram and digitalis blood level, is a relatively convenient and useful measure of digitalis toxicity. It is necessary consiler toxicity when severe visual dysfunction is observed in patients with digitalis therapy.
AuthorsN Nagai, H Ohde, Y Betsuin, S Matsukura, K Kigasawa, Y Mashima, Y Oguchi
JournalNippon Ganka Gakkai zasshi (Nippon Ganka Gakkai Zasshi) Vol. 105 Issue 1 Pg. 24-30 (Jan 2001) ISSN: 0029-0203 [Print] Japan
PMID11210783 (Publication Type: Case Reports, English Abstract, Journal Article)
Chemical References
  • Digoxin
Topics
  • Aged
  • Digoxin (poisoning)
  • Electroretinography
  • Humans
  • Male
  • Middle Aged
  • Scotoma (chemically induced)
  • Visual Acuity (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: